Cutaneous B cell pseudolymphomas
- Rein Willemze, MD
Rein Willemze, MD
- Professor and Chairman, Department of Dermatology
- Leiden University Medical Center
The term cutaneous pseudolymphoma refers to a heterogeneous group of benign skin disorders that simulate cutaneous lymphomas histologically and sometimes clinically. Cutaneous pseudolymphomas can be separated into two major subtypes, pseudolymphomas mimicking a cutaneous B cell lymphoma (B cell pseudolymphomas) and pseudolymphomas mimicking a cutaneous T cell lymphoma (T cell pseudolymphomas) (table 1) [1,2].
Cutaneous B cell pseudolymphomas (previously called lymphadenosis benigna cutis, lymphocytoma cutis, pseudolymphoma of Spiegler-Fendt, or cutaneous lymphoid hyperplasia) represent a reactive B-cell proliferation response to a variety of antigenic stimuli, including arthropod bites, gold pierced earrings, and tattoo dyes. They usually present as erythematous nodules or plaques that simulate indolent primary cutaneous B cell lymphomas, in particular primary cutaneous marginal zone lymphoma (PCMZL) or primary cutaneous follicle center lymphoma (PCFCL).
This topic will discuss the pathogenesis, clinical presentation, and differential diagnosis of B cell pseudolymphomas. Primary cutaneous B cell lymphomas, cutaneous T cell pseudolymphomas, and lymphomatoid papulosis are discussed separately.
- Rijlaarsdam JU, Willemze R. Cutaneous pseudolymphomas: classification and differential diagnosis. Semin Dermatol 1994; 13:187.
- Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol 1998; 38:877.
- Glatz M, Resinger A, Semmelweis K, et al. Clinical spectrum of skin manifestations of Lyme borreliosis in 204 children in Austria. Acta Derm Venereol 2015; 95:565.
- Colli C, Leinweber B, Müllegger R, et al. Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases. J Cutan Pathol 2004; 31:232.
- Bernstein H, Shupack J, Ackerman B. Cutaneous pseudolymphoma resulting from antigen injections. Arch Dermatol 1974; 110:756.
- Iwatsuki K, Yamada M, Takigawa M, et al. Benign lymphoplasia of the earlobes induced by gold earrings: immunohistologic study on the cellular infiltrates. J Am Acad Dermatol 1987; 16:83.
- Rijlaarsdam JU, Bruynzeel DP, Vos W, et al. Immunohistochemical studies of lymphadenosis benigna cutis occurring in a tattoo. Am J Dermatopathol 1988; 10:518.
- Cerroni L, Borroni RG, Massone C, et al. Cutaneous B-cell pseudolymphoma at the site of vaccination. Am J Dermatopathol 2007; 29:538.
- Paley K, Geskin LJ, Zirwas MJ. Cutaneous B-cell pseudolymphoma due to paraphenylenediamine. Am J Dermatopathol 2006; 28:438.
- Maubec E, Pinquier L, Viguier M, et al. Vaccination-induced cutaneous pseudolymphoma. J Am Acad Dermatol 2005; 52:623.
- Li C, Inagaki H, Kuo TT, et al. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 asian cases. Am J Surg Pathol 2003; 27:1061.
- Wood GS, Kamath NV, Guitart J, et al. Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States. J Cutan Pathol 2001; 28:502.
- Moreno A, Curcó N, Serrano T, et al. Disseminated, miliarial type lymphocytoma cutis. A report of two cases. Acta Derm Venereol 1991; 71:334.
- Arnež M, Ružić-Sabljić E. Borrelial Lymphocytoma in Children. Pediatr Infect Dis J 2015; 34:1319.
- Cerroni L, Signoretti S, Höfler G, et al. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol 1997; 21:1307.
- Arai E, Shimizu M, Hirose T. A review of 55 cases of cutaneous lymphoid hyperplasia: reassessment of the histopathologic findings leading to reclassification of 4 lesions as cutaneous marginal zone lymphoma and 19 as pseudolymphomatous folliculitis. Hum Pathol 2005; 36:505.
- Rijlaarsdam JU, Meijer CJ, Willemze R. Differentiation between lymphadenosis benigna cutis and primary cutaneous follicular center cell lymphomas. A comparative clinicopathologic study of 57 patients. Cancer 1990; 65:2301.
- Leinweber B, Colli C, Chott A, et al. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern. Am J Dermatopathol 2004; 26:4.
- Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105:3768.
- Rijlaarsdam U, Bakels V, van Oostveen JW, et al. Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: differential diagnostic and pathogenetic aspects. J Invest Dermatol 1992; 99:749.
- Gilliam AC, Wood GS. Cutaneous lymphoid hyperplasias. Semin Cutan Med Surg 2000; 19:133.
- Nihal M, Mikkola D, Horvath N, et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum Pathol 2003; 34:617.
- Senff NJ, Hoefnagel JJ, Jansen PM, et al. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol 2007; 25:1581.
- Rijlaarsdam JU, van der Putte SC, Berti E, et al. Cutaneous immunocytomas: a clinicopathologic study of 26 cases. Histopathology 1993; 23:117.
- Swerdlow SH, Quintanilla-Martinez L, Willemze R, Kinney MC. Cutaneous B-cell lymphoproliferative disorders: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol 2013; 139:515.
- Kodama K, Massone C, Chott A, et al. Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 2005; 106:2491.
- de Leval L, Harris NL, Longtine J, et al. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification. Am J Surg Pathol 2001; 25:732.
- Hoefnagel JJ, Vermeer MH, Jansen PM, et al. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance. Br J Dermatol 2003; 149:1183.
- de Leval L, Braaten KM, Ancukiewicz M, et al. Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlation. Am J Surg Pathol 2003; 27:1269.
- Taylor RB, Fortney JA, Pollack RB, et al. Radiation therapy for B-cell cutaneous lymphoid hyperplasia. Jpn J Radiol 2010; 28:385.
- Olson LE, Wilson JF, Cox JD. Cutaneous lymphoid hyperplasia: results of radiation therapy. Radiology 1985; 155:507.
- Benchikhi H, Bodemer C, Fraitag S, et al. Treatment of cutaneous lymphoid hyperplasia with thalidomide: report of two cases. J Am Acad Dermatol 1999; 40:1005.
- Pham-Ledard A, Vergier B, Doutre MS, Beylot-Barry M. Disseminated cutaneous lymphoid hyperplasia of 12 years' duration triggered by vaccination. Dermatology 2010; 220:176.
- Martin SJ, Duvic M. Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab. Clin Lymphoma Myeloma Leuk 2011; 11:286.
- ETIOLOGY AND PATHOGENESIS
- CLINICAL PRESENTATION
- Clinical course
- Clonality analysis
- DIFFERENTIAL DIAGNOSIS
- Primary cutaneous marginal zone lymphoma
- - Are cutaneous B cell pseudolymphoma and PCMZL a disease spectrum?
- Primary cutaneous follicle center lymphoma
- Secondary cutaneous follicular lymphoma
- SUMMARY AND RECOMMENDATIONS